Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study
oleh: Victoria P Werth, Richard A Furie, Ying Ye, Xiaojiang Zhan, Peter H Schafer, Nikolay Delev, Shimon Korish, Michael Weiswasser, Douglas R Hough, Allison Gaudy
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2022-02-01 |
Deskripsi
No description available for this item.